Table of Contents
ALEXANDRIA, Va. – After the Food and Drug Administration announced a one-year delay of its enforcement of Drug Supply Chain Security Act interoperability provisions, the National Community Pharmacists Association released the following reaction from CEO B. Douglas Hoey:
“We’re grateful to the FDA for listening to NCPA’s concerns and from others in the pharmacy space who are working to comply while also minimizing any delays of patient care that may result from new requirements. There are many complexities associated with implementing DSCSA. This additional time will be beneficial to ensuring that all sectors of the pharmaceutical supply chain are sufficiently prepared and helping prevent any unintended consequences impacting patient care.”
NCPA had previously joined other pharmacy organizations in asking for a delay of these provisions.
